Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial of Trastuzumab Rezetecan for unresectable locally recurrent or metastatic breast cancer is listed as not yet recrui…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy. [Phase 3]
Phase 3 trial evaluating the efficacy and safety of HRS-8080 in combination with dalpiciclib for locally advanced or metastatic breast cance…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating peri-operative immune checkpoint inhibition with cryoablation in women with triple-negative breast cancer;…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Adherence to Oral Therapies in Advanced Breast and Prostate Cancers [NA]
A completed clinical trial update examining adherence to oral therapies in patients with advanced breast cancer and advanced prostate cancer…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy [NA]
Recruiting trial evaluating hormone replacement therapy after risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Phase 1/2 study of the PARG inhibitor ETX-19477 in patients with advanced solid malignancies is currently recruiting, including breast cance…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Enhancing Pain Management Among Patients Diagnosed With Stage III and Stage IV of Breast Cancer: The Power of Immersive and Non-Immersive Virtual Reality-Driven Interactive Guided Imagery [NA]
This clinical trial examines immersive and non-immersive virtual reality-guided imagery to improve pain management in patients with stage II…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Combination Study of SV-BR-1-GM With Retifanlimab [Phase 1, Phase 2]
BriaCell Therapeutics Corporation completed a Phase 1/2 trial evaluating the combination of SV-BR-1-GM with retifanlimab in breast cancer, i…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Scarless Advanced Breast Extended Oncoplasty: The ScarABEO Study
Sponsored by Istituto Oncologico Veneto IRCCS, the ScarABEO trial is evaluating Scarless Advanced Breast Extended Oncoplasty for breast canc…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Robustness Evaluation of Deep Inspiration Breath-Hold (DIBH) Plans in Internal Mammary Irradiation
An ongoing clinical trial is evaluating the robustness of Deep Inspiration Breath-Hold plans for internal mammary irradiation in breast canc…
-
FDA approval · 2026-03-26FDA Approved: KADCYLA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for KADCYLA (ado-trastuzumab emtansine) submitted by Genentech, Inc. The approval updates the drug's…
-
EMA approval · 2026-03-25EMA Authorised: Orserdu (elacestrant) — Stemline Therapeutics B.V.
The European Medicines Agency authorised Orserdu (elacestrant) for ER-positive, HER2-negative advanced or metastatic breast cancer; decision…
-
EMA approval · 2026-03-25EMA Authorised: Zirabev (bevacizumab) — Pfizer Europe MA EEIG
Zirabev (bevacizumab) has been authorised by EMA for multiple cancer indications, including colorectal, breast, non-small cell lung, renal c…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... [Phase 1, Phase 2]
A Phase I/II clinical trial assessing durvalumab in combination with olaparib and/or cediranib for advanced solid tumors, including colorect…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease [Phase 3]
Phase 3 trial comparing BGB-43395 plus letrozole to a CDK4/6 inhibitor plus letrozole in first-line, advanced or metastatic HR+/HER2- breast…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Prospective Evaluation of Targeted Axillary Dissection (TAD) [NA]
This clinical trial update reports the completed prospective evaluation of targeted axillary dissection for breast cancer sponsored by the U…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Three Fraction Accelerated Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-risk Stage 0 and I Breast Carcinoma [NA]
This clinical trial update describes a study evaluating three-fraction accelerated partial breast irradiation as the sole radiation therapy …
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Utility of a Mobile Application for Young Women With Breast Cancer [NA]
A clinical trial update describes a mobile application study for young women with breast cancer, currently recruiting. The sponsor is Wake F…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Photo-Acoustic and Ultrasonographic Mammoscope [Phase 2]
A Phase 2 clinical trial evaluating a photo-acoustic and ultrasonographic mammoscope for breast lesions is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Breast Cancer Study Tracking Risk Awareness of Alcohol Consumption and Improving Knowledge in Young Adult Women [NA]
An Ohio State University Comprehensive Cancer Center trial aimed at increasing breast cancer risk awareness related to alcohol use among you…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial [Phase 3]
Phase 3 trial evaluating long-term outcomes of lidocaine infusions for postoperative pain in breast cancer surgery; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: REBECCA Real-world Early BrEast CanCer mAnagement
The REBECCA trial, investigating real-world management of early breast cancer, is currently recruiting with AstraZeneca as sponsor.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Breast Tumour Size Measurement by Field Cycling Imaging
This clinical trial update describes a University of Aberdeen study evaluating breast tumor size measurement using field cycling imaging; th…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer [NA]
This clinical trial is evaluating an exercise therapy program to improve cardiovascular health in post-menopausal women after treatment for …
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Behavioral Pain Intervention for Older Cancer Patients [NA]
Duke University is conducting a behavioral pain intervention trial for older cancer patients with breast cancer, and the study has not yet s…